Nuclera (Series C)
Funding Details
Awarder
RSS - feeds.feedburner.com
Date Award
January 15, 2026
Vertical
Biotechnology
Funding Amount
$12,000,000
Company Info
Market
Drug Discovery
Location
Boston, MA, USA
Coinvestors
Elevage Medical Technologies, Jonathan Milner, British Business Bank, GK Goh
Company Description

Nuclera is a biotechnology company accelerating drug discovery by providing rapid, easy access to functional proteins through its benchtop eProtein Discovery™ System.

Links